Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $131,589 | 79 | 77.2% |
| Consulting Fee | $17,630 | 9 | 10.3% |
| Food and Beverage | $12,046 | 522 | 7.1% |
| Travel and Lodging | $8,933 | 22 | 5.2% |
| Education | $231.84 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $105,968 | 183 | $0 (2024) |
| Allergan, Inc. | $59,834 | 143 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $883.87 | 50 | $0 (2023) |
| PFIZER INC. | $497.96 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $462.14 | 32 | $0 (2024) |
| LEO Pharma Inc. | $395.48 | 35 | $0 (2019) |
| Celgene Corporation | $370.78 | 25 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $281.75 | 28 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $263.90 | 7 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $238.76 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,422 | 127 | ABBVIE INC. ($52,850) |
| 2023 | $54,503 | 90 | ABBVIE INC. ($52,686) |
| 2022 | $18,694 | 65 | Allergan, Inc. ($18,407) |
| 2021 | $32,690 | 43 | Allergan, Inc. ($32,561) |
| 2020 | $521.72 | 20 | Allergan, Inc. ($211.84) |
| 2019 | $2,354 | 89 | Allergan Inc. ($1,406) |
| 2018 | $2,483 | 103 | Allergan Inc. ($1,221) |
| 2017 | $5,762 | 101 | Allergan Inc. ($4,515) |
All Payment Transactions
638 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,780.65 | General |
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/17/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $248.24 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $55.79 | General |
| 11/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $816.06 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $733.35 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $248.24 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $41.60 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $652.80 | General |
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $141.16 | General |
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.43 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.43 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,317 | 4,920 | $450,483 | $164,332 |
| 2022 | 20 | 2,463 | 5,109 | $493,545 | $181,618 |
| 2021 | 19 | 2,393 | 5,303 | $481,101 | $179,305 |
| 2020 | 17 | 2,157 | 4,482 | $403,742 | $137,057 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 697 | 1,009 | $141,260 | $58,448 | 41.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 328 | 413 | $81,361 | $26,447 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 441 | 600 | $76,200 | $22,881 | 30.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 87 | 113 | $32,431 | $11,259 | 34.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 347 | 2,244 | $24,684 | $10,498 | 42.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 45 | 60 | $20,040 | $6,840 | 34.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 80 | 147 | $9,261 | $5,435 | 58.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $17,138 | $5,373 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 62 | $12,896 | $5,181 | 40.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $11,540 | $3,463 | 30.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 31 | 43 | $8,987 | $3,292 | 36.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 21 | $5,754 | $1,911 | 33.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 51 | $4,284 | $1,729 | 40.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,167 | $939.31 | 43.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 20 | $2,120 | $619.26 | 29.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 24 | $360.00 | $17.04 | 4.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 677 | 967 | $135,380 | $57,434 | 42.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 353 | 448 | $88,256 | $28,675 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 450 | 605 | $76,835 | $22,834 | 29.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 80 | 109 | $31,283 | $11,747 | 37.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 350 | 2,333 | $25,663 | $10,677 | 41.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 36 | 36 | $20,772 | $7,750 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 119 | 119 | $24,871 | $7,016 | 28.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 43 | 55 | $18,370 | $6,453 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 68 | $14,144 | $5,633 | 39.8% |
About Dr. Mona Foad, MD
Dr. Mona Foad, MD is a Dermatology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316011661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mona Foad, MD has received a total of $170,430 in payments from pharmaceutical and medical device companies, with $53,422 received in 2024. These payments were reported across 638 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($131,589).
As a Medicare-enrolled provider, Foad has provided services to 9,330 Medicare beneficiaries, totaling 19,814 services with total Medicare billing of $662,312. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Cincinnati, OH
- Active Since 11/20/2006
- Last Updated 10/28/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1316011661
Products in Payments
- BOTOX (Biological) $31,811
- COSENTYX (Biological) $769.86
- EUCRISA (Drug) $497.96
- Otezla (Drug) $370.78
- ENSTILAR (Drug) $370.34
- Sotyktu (Drug) $281.75
- Humira (Biological) $227.80
- SKYRIZI (Biological) $204.88
- XEOMIN (Biological) $134.44
- BOTOX COSMETIC (Biological) $129.71
- SIMPONI ARIA (Biological) $123.85
- Cimzia (Drug) $120.02
- ILUMYA (Biological) $115.29
- DORYX (Drug) $113.73
- REMICADE (Biological) $113.25
- TALTZ (Drug) $112.29
- DUPIXENT DUPILUMAB INJECTION (Biological) $98.00
- TREMFYA (Drug) $85.53
- Tremfya (Drug) $79.17
- AMZEEQ (Drug) $78.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Cincinnati
Alan Fleischer, Md, MD
Dermatology — Payments: $34,072
Bria Barjuca, Aprn-Cnp, APRN-CNP
Dermatology — Payments: $12,688
Dr. Drore Eisen, M.d, M.D
Dermatology — Payments: $10,499
Mona Mislankar, M.d, M.D
Dermatology — Payments: $8,503
Kristine Zitelli, M.d, M.D
Dermatology — Payments: $6,712
Debra Breneman, M. D, M. D
Dermatology — Payments: $5,957